Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFIX
2076
Stitch Fix
SFIX
$560M
| $2.34M | ﹤0.01% |
38,795
-99,476
| -72% | -$5.09M |
|
2077
Veeco
VECO
$3.23B
| $2.33M | ﹤0.01% |
96,958
-56,275
| -37% | -$1.29M |
|
2078
Ultragenyx Pharmaceutical
RARE
$2.55B
| $2.33M | ﹤0.01% |
24,380
-47,296
| -66% | -$4.93M |
|
2079
Viper Energy
VNOM
$14.7B
| $2.32M | ﹤0.01% |
123,372
-11,673
| -9% | -$209K |
|
2080
CALL
Golar LNG
GLNG
$5.13B
| $2.32M | ﹤0.01% |
+175,000
| New | +$2.08M |
|
2081
Buckle
BKE
$2.37B
| $2.31M | ﹤0.01% |
46,520
-63
| -0.1% | -$2.68K |
|
2082
Jack in the Box
JACK
$335M
| $2.31M | ﹤0.01% |
20,754
-3,906
| -16% | -$457K |
|
|
DRNA
2083
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.31M | ﹤0.01% |
61,910
-65,707
| -51% | -$2.01M |
|
2084
Strategic Education
STRA
$1.92B
| $2.31M | ﹤0.01% |
30,359
+4,689
| +18% | +$374K |
|
2085
CALL
Enbridge
ENB
$112B
| $2.3M | ﹤0.01% |
+57,500
| New | +$2.23M |
|
2086
Eldorado Gold
EGO
$9.89B
| $2.3M | ﹤0.01% |
230,874
-40,379
| -15% | -$449K |
|
2087
Alarm.com
ALRM
$2.85B
| $2.29M | ﹤0.01% |
27,009
-32,650
| -55% | -$2.79M |
|
2088
BancFirst
BANF
$3.8B
| $2.28M | ﹤0.01% |
36,600
+4,484
| +14% | +$309K |
|
|
FRTA
2089
DELISTED
Forterra, Inc
FRTA
| $2.27M | ﹤0.01% |
96,774
-33,554
| -26% | -$786K |
|
2090
HNI Corp
HNI
$3.59B
| $2.27M | ﹤0.01% |
51,600
-6,591
| -11% | -$286K |
|
|
BCPC
2091
Balchem Corp
BCPC
$5.72B
| $2.27M | ﹤0.01% |
17,287
-23,174
| -57% | -$2.98M |
|
2092
Mercury Insurance
MCY
$6.07B
| $2.27M | ﹤0.01% |
34,919
+12,107
| +53% | +$767K |
|
2093
Glaukos
GKOS
$10.6B
| $2.26M | ﹤0.01% |
26,641
-30,030
| -53% | -$2.47M |
|
2094
CALL
Transocean
RIG
$5.82B
| $2.26M | ﹤0.01% |
500,000
+100,000
| +25% | +$379K |
|
2095
Sumitomo Mitsui Financial
SMFG
$164B
| $2.26M | ﹤0.01% |
328,015
+38,649
| +13% | +$277K |
|
2096
Monro
MNRO
$398M
| $2.26M | ﹤0.01% |
35,534
-5,797
| -14% | -$383K |
|
2097
JELD-WEN Holding
JELD
$164M
| $2.25M | ﹤0.01% |
85,669
-50,104
| -37% | -$1.42M |
|
|
CUTR
2098
DELISTED
Cutera, Inc.
CUTR
| $2.25M | ﹤0.01% |
45,823
-25,118
| -35% | -$922K |
|
2099
First Commonwealth Financial
FCF
$2.17B
| $2.24M | ﹤0.01% |
159,487
-15,197
| -9% | -$223K |
|
2100
CALL
CSX Corp
CSX
$93.1B
| $2.24M | ﹤0.01% |
69,900
| – | – |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.